Search - tctmd.com

Displaying 1 - 20 of 86

Sort: Relevancy | Date

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Daily News

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

L.A. McKeown

December 03, 2024

News Daily News

Different Guidelines for Acute PE Offer a Mixed Bag of Advice

Caitlin E. Cox

October 08, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

News Daily News

High-Sensitivity Troponins May Overestimate PE Severity

L.A. McKeown

November 28, 2023

News Daily News

FDA Approves Blood Flow-Diverting LimFlow System for No-Option CLTI

L.A. McKeown

September 12, 2023

News Daily News

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

L.A. McKeown

March 29, 2023

News Daily News

Lasers a Valuable Tool to Retrieve Embedded IVC Filters: Multicenter Study

Caitlin E. Cox

December 30, 2022

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Daily News

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

Todd Neale

October 19, 2022

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

News Daily News

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

L.A. McKeown

August 05, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Daily News

Percutaneous Axillary Access: SCAI Calls for Best Practices

Caitlin E. Cox

April 20, 2022

News Daily News

PAD Significantly Ups Morbidity and Mortality in AMICS

L.A. McKeown

March 29, 2022

News Daily News

Two Large Studies Affirm Rare Thrombosis Risk With ChAdOx1 COVID-19 Vax

Michael O'Riordan

February 23, 2022

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Caitlin E. Cox

December 28, 2021

Advertisement

Top Endovascular News of 2024

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

Different Guidelines for Acute PE Offer a Mixed Bag of Advice

Scientific Statement Reviews Current Antithrombotic Options in PAD

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

High-Sensitivity Troponins May Overestimate PE Severity

FDA Approves Blood Flow-Diverting LimFlow System for No-Option CLTI

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

Lasers a Valuable Tool to Retrieve Embedded IVC Filters: Multicenter Study

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

Percutaneous Axillary Access: SCAI Calls for Best Practices

PAD Significantly Ups Morbidity and Mortality in AMICS

Two Large Studies Affirm Rare Thrombosis Risk With ChAdOx1 COVID-19 Vax

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content